Browsing by Author "Long, David T."

Now showing 1 - 2 of 2
  • Thumbnail Image
    Item
    Heterogeneous nuclear ribonucleoprotein E1 binds polycytosine DNA and monitors genome integrity
    (EMBO Press, 2021-07-16) Mohanty, Bidyut K.; Karam, Joseph A. Q.; Howley, Breege V.; Dalton, Annamarie C.; Grelet, Simon; Dincman, Toros; Streitfeld, William S.; Yoon, Je-Hyun; Balakrishnan, Lata; Chazin, Walter J.; Long, David T.; Howe, Phillip H.; Biology, School of Science
    Heterogeneous nuclear ribonucleoprotein E1 (hnRNP E1) is a tumor suppressor protein that binds site- and structure-specifically to RNA sequences to regulate mRNA stability, facilitate alternative splicing, and suppress protein translation on several metastasis-associated mRNAs. Here, we show that hnRNP E1 binds polycytosine-rich DNA tracts present throughout the genome, including those at promoters of several oncogenes and telomeres and monitors genome integrity. It binds DNA in a site- and structure-specific manner. hnRNP E1-knockdown cells displayed increased DNA damage signals including γ-H2AX at its binding sites and also showed increased mutations. UV and hydroxyurea treatment of hnRNP E1-knockdown cells exacerbated the basal DNA damage signals with increased cell cycle arrest, activation of checkpoint proteins, and monoubiquitination of proliferating cell nuclear antigen despite no changes in deubiquitinating enzymes. DNA damage caused by genotoxin treatment localized to hnRNP E1 binding sites. Our work suggests that hnRNP E1 facilitates functions of DNA integrity proteins at polycytosine tracts and monitors DNA integrity at these sites.
  • Thumbnail Image
    Item
    Uncoupling of p97 ATPase activity has a dominant negative effect on protein extraction
    (Springer Nature, 2019-07-17) Rycenga, Halley B.; Wolfe, Kelly B.; Yeh, Elizabeth S.; Long, David T.; Pharmacology & Toxicology, IU School of Medicine
    p97 is a highly abundant, homohexameric AAA+ ATPase that performs a variety of essential cellular functions. Characterized as a ubiquitin-selective chaperone, p97 recognizes proteins conjugated to K48-linked polyubiquitin chains and promotes their removal from chromatin and other molecular complexes. Changes in p97 expression or activity are associated with the development of cancer and several related neurodegenerative disorders. Although pathogenic p97 mutations cluster in and around p97's ATPase domains, mutant proteins display normal or elevated ATPase activity. Here, we show that one of the most common p97 mutations (R155C) retains ATPase activity, but is functionally defective. p97-R155C can be recruited to ubiquitinated substrates on chromatin, but is unable to promote substrate removal. As a result, p97-R155C acts as a dominant negative, blocking protein extraction by a similar mechanism to that observed when p97's ATPase activity is inhibited or inactivated. However, unlike ATPase-deficient proteins, p97-R155C consumes excess ATP, which can hinder high-energy processes. Together, our results shed new insight into how pathogenic mutations in p97 alter its cellular function, with implications for understanding the etiology and treatment of p97-associated diseases.